Literature DB >> 504694

Role of arachidonic acid derivatives in neutrophil aggregation: a hypothesis.

J T O'Flaherty, H J Showell, E L Becker, P A Ward.   

Abstract

Chemotactic substances stimulate neutrophils in suspension to aggregate. Arachidonic acid (but not several structurally related fatty acids) induces a similar neutrophil response. We now report that two blockers of arachidonic acid metabolism, indomethacin and 5,8,11,14-eicosatetraynoic acid, inhibit this arachidonic acid-mediated response. Moreover, both blockers also inhibit aggregation stimulated by a synthetic chemotactic tripeptide, formyl-methionyl-leucyl-phenylalanine, and their potency in doing so parallels their potency in inhibiting the response to arachidonic acid. These results suggest that metabolites of arachidonic acid may stimulate certain neutrophil functions and be involved in cellular responses to at least some chemotactic substances.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 504694     DOI: 10.1016/0090-6980(79)90062-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  15 in total

1.  Arachidonic acid and LTB4 enhance aggregation of psoriatic peripheral blood mononuclear leukocytes in vitro.

Authors:  P D Pigatto; M M Polenghi; G F Altomare; G L Tadini; S Villa
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Vitamin E and vitamin C inhibit arachidonate-induced aggregation of human peripheral blood leukocytes in vitro.

Authors:  S Villa; A Lorico; G Morazzoni; G de Gaetano; N Semeraro
Journal:  Agents Actions       Date:  1986-10

3. 

Authors:  R Rochels
Journal:  Doc Ophthalmol       Date:  1984-05       Impact factor: 2.379

4.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

5.  Effect of calcium, magnesium, and cytochalasin B on arachidonic acid-induced neutrophil aggregation.

Authors:  J T O'Flaherty
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

6.  Human polymorphonuclear neutrophil activation with arachidonic acid.

Authors:  R J Smith; L M Sam; J M Justen; K L Leach; D E Epps
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

7.  Inhibition of neutrophil response by curcumin.

Authors:  R Srivastava
Journal:  Agents Actions       Date:  1989-11

8.  In vitro effects of leukotriene B4 (LTB4) on canine PMN effector function(s).

Authors:  D F Gruber; M M D'Alesandro; T L Walden
Journal:  Agents Actions       Date:  1989-11

9.  Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.

Authors:  C Dahinden; J Fehr
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Inhibition of human neutrophil secondary granule discharge by antiinflammatory agents.

Authors:  J Davies; K Sheppard; J Fletcher
Journal:  Inflammation       Date:  1984-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.